Inhalation Sciences Sweden AB Stock

Equities

ISAB

SE0009983893

Advanced Medical Equipment & Technology

End-of-day quote NORDIC GROWTH MARKET 18:00:00 2024-01-30 EST 5-day change 1st Jan Change
4.34 SEK +6.90% Intraday chart for Inhalation Sciences Sweden AB -.--% +7.43%

Financials

Sales 2024 * 38.3M 3.5M 4.79M Sales 2025 * 65.8M 6.01M 8.22M Capitalization 65.83M 6.02M 8.23M
Net income 2024 * - Net income 2025 * - EV / Sales 2024 * 1.45 x
Net cash position 2024 * 10.3M 942K 1.29M Net cash position 2025 * - 0 0 EV / Sales 2025 * 1 x
P/E ratio 2024 *
-
P/E ratio 2025 *
-
Employees 8
Yield 2024 *
-
Yield 2025 *
-
Free-Float 70.14%
More Fundamentals * Assessed data
Dynamic Chart
1 day+6.90%
3 months+3.58%
6 months-9.21%
Current year+7.43%
More quotes
Current year
3.85
Extreme 3.85
4.99
1 year
2.43
Extreme 2.43
4.99
3 years
2.43
Extreme 2.43
12.50
5 years
2.43
Extreme 2.43
14.55
10 years
2.43
Extreme 2.43
15.48
More quotes
Managers TitleAgeSince
Chief Executive Officer - 18-11-30
Founder - 04-12-31
- -
Members of the board TitleAgeSince
Chairman - 20-04-30
Founder - 04-12-31
Chief Executive Officer - 18-11-30
More insiders
Inhalation Sciences Sweden AB is a Sweden-based company, which develops and sells labtech equipment for inhalation research. The Company’s primary product is PreciseInhale, which is a laboratory system that lets scientists measure how inhaled particles act in lungs and affect human health. PreciseInhale is a dry powder aerosol research and development system, which generate aerosols and data of a quality. The system helps to eliminate poor candidate drugs before clinical trials. The secondary product is LaminarPace, a tool for drying small amounts of drug substance. The Company’s customers comprise Dow Chemical Group, Kings College London and Karolinska Institutet, among others. The Company’s main shareholder is Nordnet Pensionsforsakring.
More about the company

Quarterly revenue - Rate of surprise